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Human Eosinophil Hematopoiesis Studied in vitro by Means of Murine Eosinophil
Differentiation Factor (1L5): Production of Functionally Active Eosinophils
From Normal Human Bone Marrow
By Elaine J. Clutterbuck and Cohn J. Sanderson
The production of human eosinophils in vitro from normal
bone marrow by using murine eosinophil differentiation
factor (mEDF/interleukin 5) is described. Eosinophil pro-
duction was selective and first detectable after 14 days and
reached a peak between 21 and 35 days when they were
the predominant cell type (41 % to 89%). Until day 14. all
the eosinophils were typical myelocytes. developing there-
after into metamyelocytes and mature cells. All cell types
had characteristic light- and electron-microscopic fea-
tures. apart from the absence of granules with crystalline
cores. The eosinophils produced were readily recovered.
and both immature myelocytes and mature cells were
functionally active in an antibody-dependent. cell-mediated
cytotoxicity assay. mEDF added into the assay enhanced
the cytotoxicity but to a lower degree than previously
reported for peripheral blood eosinophils. which suggests
that they may be partially activated. The possibility that
eosinophils could be deactivated was tested by removing
mEDF from the culture medium. The eosinophils retained
viability and functional activity. however. and showed no
increased ability to be activated by mEDF for up to six days
after removing the mEDF. The liquid culture of human bone
marrow was shown to be an alternative assay for eosino-
phil differentiation factors to colony formation.
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patients with hypereosinophilia is the usual source
from which eosinophils are obtained to study their functional
activity.’ Morphological differentiation has been studied by
observing eosinophil colony formation in bone marrow cul-
tured in soft agar2’3; however, this method does not allow the
eosinophils to be recovered for use in functional studies. A
technique for the production of eosinophils under controlled
conditions in liquid culture would provide a basis for the
study of the factors involved in differentiation and activa-
tion.
Murine eosinophil differentiation factor (mEDF)/inter-
leukin 5 produced by the murine T cell hybrid NIMP-TH14
selectively stimulates human eosinophil colony formation
and activates mature eosinophils.5 Because no native human
analogue has yet been characterized, this cross-species reac-
tivity of mEDF provided a means for studying eosinophil
production in vitro.
We demonstrate that mEDF induces a selective prolifera-
tion of easily recovered eosinophils of normal morphology
which are functionally active both as immature myelocytes
and mature cells. The only system available for the assay and
standardization of factors involved in human eosinophil
production has been the production of colonies in soft agar,6
but in the mouse a liquid culture system combined with an
assay for eosinophil peroxidase (EPO) has provided a simple,
specific and nonsubjective assay for mEDF.7 We have opti-
mized a human liquid culture system as an assay for EDFs.
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MATERIALS AND METHODS
Preparation of mEDF. mEDF was prepared from conditioned
medium (CM) of the T cell hybrid NIMP-TH 1 4,8 In some experi-
ments mEDF-CM was partially purified (mEDF-PP) by 45% to
80% ammonium sulphate precipitation and by binding to lentil lectin
(LcA-Sepharose, Pharmacia, Uppsala, Sweden) and eluting with
0.1 mol/L a-methyl mannoside. No difference was found between
mEDF-CM and mEDF-PP.
Human bone marrow cells. Human bone marrow was obtained
from normal patients (peripheral blood eosinophil count less than
3%) who were donating marrow for allotransplantation at The Royal
Free Hospital and Hammersmith Hospital, London, in accordance
with a protocol approved by their local ethics committees. We are
very grateful to Drs E. Gordon-Smith, M. Brenner, and H. Hislop
for making this material available. After centrifugation over Ficoll-
Paque ( I .077 g/mL, Pharmacia), mononuclear cells were recovered
from the interface and resuspended at 106 cells/mL in RPMI 1640
containing 15% fetal calfserum (FCS).7
Liquid culture system. A quantity of 10#{176} marrow mononuclear
cells was cultured with diluted stimuli in 96-well round-bottomed
microplates (Nunc, Roskilde, Denmark) at 37#{176}C in humidified 5%
CO2 in air. At seven- to 14-day intervals, 50 ML of the supernatant
was replaced with fresh medium containing 5 ￿oL of the appropriate
stimulus. Unless stated otherwise in the text, when present in the
culture medium mEDF was used at a final dilution of 1: 10. After the
culture period indicated in the text, the cells were resuspended and
counted with a Coulter Counter (Coulter Electronics, Hialeah, FL)
and differential cell counts performed on cytocentrifuge prepara-
tions. These were stained with 0.1% Luxol fast blue in urea-
saturated 70% ethanol and Harris’ acidified hematoxylin, May-
GrDnwald-Giemsa, or Congo red and Harris’ acidified hematoxylin.
Cell viability was assessed by trypan blue exclusion.
For functional assays the cells were washed in fresh culture
medium without mEDF and resuspended at a concentration of
1.63 x lO6cells/mL in HEPES-buffered RPMI l640containing 5%
FCS, and 80-￿uL aliquots (containing I .3 x 10#{176} cells) were taken as
effector cells.
Murine cultures were performed by using femoral bone marrow
from Mesocestoides corti-parasitised BALB/c NIMR mice.7 The
peroxidase (EPO) assay was performed on both the human and
murine cultures as described by Strath et al.#{176}
Colony-forming assay. A quantity of 8 x Io￿ mononuclear cells
was incubated in medium containing diluted stimuli and 0.33%
Bacto-Agar (Difco, Detroit) in 0.4-mL aliquots in leukocyte migra-
tion plates (Sterilin, Ltd, Teddington, England) at 37#{176}C in 5% CO2
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in air for seven to 21 days. The cultures were methanol-fixed and
stained with either Luxol fast blue and Harris’ acidified hematoxylin
or Congro red and toluidine blue and all colonies (groups of more
than 40 cells) counted.
Electron microscopy. Cells cultured in the liquid assay in the
presence of optimal concentrations of mEDF were fixed with 1%
paraformaldehyde and 1.25% glutaraldehyde in 0.1 mol/L sodium
cacodylate buffer, pH 7.25, followed by 1% osmium tetroxide in the
same buffer and then I % aqueous uranyl acetate. After dehydrating
with absolute ethanol they were embedded in araldite and post-
stained with uranyl acetate and Reynold’s lead citrate.
Antibody-dependent, cell-mediated cytotoxicity assay. The
ADCC assay previously described by Vadas et a19 was used with
minor modifications. Briefly, 40 zL (4 x 10#{176}) #{176}‘Cr-labeled P815
mastocytoma cells were incubated in V-bottomed radioimmunoas-
say vials (Sarstedt, Leicester, England) with 24 ￿zL rabbit anti-P8 15
antiserum, 16 zL stimulus (culture medium or mEDF), and 80 zL
(1.3 x l0￿) effector cells. After three hours at 37#{176}C, 80 ￿uL of the
supernatant was removed and 5tCr release determined. The percent
cytotoxicity was calculated according to the following formula:
100 x (test - control)/(total - control), where control is the 51Cr
released by P8 15 cells in the presence of medium alone, and total is
that released in the presence of 5% Triton X-100. Unless stated
otherwise in the text, the final dilution of antibody was 1:53, that of
mEDF-CM was 1:10, and the effector: target (E:T) ratio was 32:1.
Statistics. Results were expressed as means ± I SD of three or
four replicates unless stated otherwise in the text and compared by
using Student’s paired t test. Fifty percent end points were deter-
mined by linear regression using log-transformed data.
RESULTS
mEDF selectively stimulates the growth ofeosinophils in
liquid culture. Table I summarizes the complete data from
12 patients. In the absence of mEDF, total cell numbers
diminish progressively over the first 21 days, mainly because
of the loss of cells of the neutrophil and lymphocyte lineages.
Fig 1 . Time course of total cell (-) and eosinophil (- - -)
counts of six individual marrows cultured in the presence (0) of
mEDF-CM or medium alone (s). Error = 1 SD; where omitted.
errors were smaller than the symbol.
Cells remaining viable in culture thereafter are monocyte-
macrophages and lymphocytes.
Culture in the presence of mEDF causes a selective
eosinophil proliferation, with no effect on the other cell
lineages. Eosinophil production was first detectable after 14
days (P < .01) and reached a peak between days 21 and 35
depending on the individual marrow (Fig 1), although the
mean maximal eosinophil count occurred on day 21. The
Table 1 . Differential Cell Count s on Culturing Normal Human Bone Marrow in the Presence and Absence of mEDF
Days in Culture
0 14 21 35 49
CeIlType (n - 8) (n - 6) In - 12) (n - 3) In-SI
N
-
+
5.9 ± 1.6
5.9 ± 1.6
3.3 ± 3.9 0.4 ± 0.5 0.1 ± 0.1 0
2.9 ± 2.3 0.6 ± 1.0 0.1 ± 0.1 0
M
- 0.2 ± 0.3 0.7 ± 0.3 0.9 ± 0.8 0.6 ± 0.6 0.5 ± 0.2
+ 0.2 ± 0.3 1.0 ± 0.7 0.8 ± 0.5 0.4 ± 0.2 0.9 ± 0.7
L
-
+
3.9 ± 1.5
3.9 ± 1.5
2.0 ± 1.0 1.1 ± 0.8 0.7 ± 0.2 0.2 ± 0.2
2.1 ± 0.9 1.1 ± 1.1 1.0 ± 0.1 0.2 ± 0.1
E
-
+
0.1 ± 0.1
0.1 ± 0.1
0.4 ± 0.6 0.2 ± 0.1 0.1 ± 0.1 0
3.1 ± 1.6 6.0 ± 3.1 5.0 ± 3.5 1.7 ± 1.1
(P<.O1) (P<.OO1) (NS) (P<.05)
T
-
‘-
10.0 ± 1.0
10.0 ± 1.0
6.5 ± 3.8 2.8 ± 1.7 1.4 ± 0.8 0.6 ± 0.3
9.3 ± 4.3 8.7 ± 3.9 6.3 ± 3.7 2.9 ± 1.7
(P-￿z.O1) (P<.001) (NS) (NS)
Results are express ed as means ± i SD (x 1O￿ cells/mL) for n replicates. P represents the significance of the difference between counts in the
absence and presence of mEDF.
Abbreviations: N, neutrophils; M, macrophages; L, lymphocytes/monocytes; E, eosinophils; T, total cells; - . in the absence of mEDF; + , in the
presence of mEDF-CM.
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Fig 2. Electron micrographs of eosinophils induced by mEDF: (A) myelocyte. and (B) mature cell. and their granules (C) and (D).
respectively. The bar represents 1 ￿m.
eosinophil count fell over the following four weeks, although
eosinophils remained the predominant cell type, 41% to 89%
ofthe totalcells, and were more than 90%viableasjudged by
trypan blue exclusion (data not shown).
Morphological features of eosinophils cultured in
vitro. Day 14 eosinophils had the typical features of myelo-
cytes, being from I 3 to I 7 ￿tm in diameter with compact
kidney-shaped nuclei with diffuse chromatin, active Golgi
zones and endoplasmic reticula, numerous mitochondria,
and characteristic eosinophilic granules. On light microscopy
the granules stained as typical eosinophil granules with all
the stains used and were homogeneously dense on electron
microscopy (Fig 2). After day 14, the percentage of eosino-
phils with the features of metamyelocytes and mature cells
increased progressively (22%, 60%, and 97% at days 21, 35,
and 49, respectively). The mean dimensions of mature cells
were 10 to 12.5 ￿m, contained typically dense lobulated
nuclei connected by thin chromatin strands, and were devoid
of nucleoli. However, the Golgi zones were atrophied and
endoplasmic reticula more sparse than that usually found in
circulating cells. The granules were of normal size (0.6 to I
￿zm) and had electron-dense cores with less dense matrices.
No crystalline cores were seen, and there were fewer gran-
ules per cell than normally found in circulating mature
cells.
a
Activity ofeosinophils in the ADCC assay. To establish
the optimal conditions for the assay, cytotoxic activity at
different cell ratios and different antibody dilutions in the
presence of mEDF were carried out. Figure 3B shows that an
eosinophil preparation (74% eosinophil myelocytes) gave
significant cytotoxicity at an E:T ratio of 3.2:1, whereas the
control culture (containing 8% myelocytes) gave significant
cytotoxicity at a ratio of only 32: 1 . No significant cytotoxic-
ity was obtained in the absence of antibody (Fig 3C), and this
antiserum gave optimal levels of killing at a dilution of I :53
or higher. A similar response curve was obtained when the
eosinophils were assayed in the absence of mEDF (data not
shown), which indicated that there was no increased effect at
subthreshold levels of antibody. Subsequent experiments
were performed at an E:T ratio of 32:1 and an antibody
dilution of I :53.
Marrows cultured with mEDF for 21 to 39 days (contain-
ing from 75% to 87% eosinophils) caused from 18% to 40%
cytotoxicity (Fig 3A). The same marrows cultured in
medium alone contained 0% to 7% eosinophils, and all but
one caused less than 4% cytotoxicity in the three-hour assay.
(The one exception contained 7% eosinophils and caused
10% cytotoxicity.) The significance of the difference between
eosinophil and control samples was <.001. The remaining
cells in both the stimulated and control cultures were lym-
d
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Fig 4. Effect of time in culture on percent cytotoxicity of
marrow cultured in the absence (filled symbols) and presence
(open symbols) of mEDF-CM. Each symbol represents an individual
marrow. Data are means ± i SD.
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Fig 3. Percent cytotoxicity in the ADCC assay of marrow
cultured in the absence (#{149}). and presence (0) of mEDF-CM. (A)
Data for seven marrows cultured for 22 to 39 days. (B) Effect of
E:T ratio (antibody dilution. 1 :13). (C) antibody dilution on marrow
cultured for 25 days. Data are means ± i SD.
phocytes and macrophages. Thus, although the cell prepara-
tions were not pure, most of the cytotoxic activity could be
attributed to the eosinophils and very little to the contami-
nating lymphocytes and macrophages.
The effect of time in culture on the cytotoxic activity of the
eosinophils is shown in Fig 4. Marrow cultured with mEDF
contained between 37% and 91% eosinophils (43% to 99%
myelocytes until day 28, 66% to 100% metamyelocytes or
mature cells after day 35). Although there was considerable
variation between different marrows, both mature cells and
immature myelocytes caused the same degree of cytotoxicity.
Cytotoxic activity progressively declined, however, when
preparations were cultured for longer than 40 days. In three
experiments mature eosinophils cultured for 53 days,
although more than 90% viable and having normal light
microscopic appearances were no more active than control
preparations cultured in the absence of mEDF, which caused
less than 8% cytotoxicity throughout.
mEDF present during the cytotoxic assay acted as an
activating agent in 25 of 29 experiments and enhanced
cytotoxicity by a mean of 5% (range, 0% to I 3%; P < .001;
7o-
data not shown). Experiments were carried out to test the
possibility that cells could be deactivated (returned to a
resting state) by incubation in the absence of mEDF. At each
time point all the eosinophil preparations were washed once
and cells resuspended in fresh medium with or without
mEDF so that there was very little possibility of mEDF
remaining in the mEDF-deprived wells, and all cells were
subjected to the same number of medium changes. mEDF
deprivation for up to six or seven days had little effect on
eosinophil cytotoxic activity (Fig 5). Figure SB shows an
apparent increased activating effect of adding mEDF to the
cultures after six to nine days’ deprivation, but this effect was
relatively small. Furthermore, eosinophil numbers were
maintained for relatively prolonged periods in the absence of
mEDF: 70% of the initial number at seven days in experi-
ment 5A, 61% at six days, and 25% at nine days in
experiment SB.
Liquid culture as an assayf’or EDFs. Counting eosino-
phil numbers was most sensitive between days 21 and 35
(data not shown), but day 21 was chosen as the optimal time
point to assay for mEDF because the cultures then only
required a single medium change. Of 22 marrow samples
assayed, mEDF induced significant eosinophil production in
all of them, with two broad groups of responders: the
majority with a high eosinophil production (4 to 9 x I0￿/
mL) and three with a tenfold-lower eosinophil count (0.4 to
0.9 x l05/mL) (Fig 6A). Although the numbers are small,
there appears to be no relationship between induced eosino-
phil production and either initial bone marrow eosinophil
count, donor age, sex, or HLA type. This system was a
reproducible assay of mEDF activity: it gave only a fourfold
variation of 50% end points (Table 2) (disregarding the three
marrows where eosinophil production did not reach a pla-
teau) and was capable of detecting mEDF activity at dilu-
tions down to I :3 x l0￿ (Fig 6A) when eosinophil counts
were two to five times the background.
Fig 5. Effect of incubating cultured eosinophils in the absence
of mEDF before the ADCC assay. (A) Day 32 marrow (80%
eosinophils. 92% to 100% myelocytes). (B) A different marrow at
day 47 (83% eosinophils. 100% mature cells). #{149}. mEDF-CM absent;
0. mEDF-CM present in the assay. Data are means ± i SEM. (a)
The eosinophil count (cell viability) was 5.5 x 10’/ml (99%). 5.9 x
10’/mL (77%). and 3.9 x 10’/mL (80%). after 0. 4. and 7 days of
EDF deprivation. (b) The eosinophil count fell from 6.4 x 10’/mL
(99% viable) to 3.9 x 10’/mL (98% viable) after six days and 1 .6 x
10’/mL (97% viable) after nine days.
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Fig 6. Dose response of (A) eosinophil count in
liquid culture on day 21 . (B) eosinophil colony
count on day 14 induced by mEDF-CM for 11
individual marrows. For clarity. error bars repro-
senting 1 SD are only shown for two marrows.
The peroxidase assay detects neutrophil myeloperoxidase,
which is not specifically inhibited by potassium cyanide.
However, peroxidase activity does assess eosinophil numbers
after day 21 when, in the absence of neutrophil growth
factors, neutrophil counts are low (data not presented). As
summarized in Table 2, although this assay was three- to
14-fold more sensitive than differential counting, the 50%
end points were more variable (tenfold). Compared with
marrow from parasitized mice, normal human bone marrow
was two- to 30-fold less sensitive at detecting mEDF when
using this assay (Table 2).
mEDF induced selective eosinophil colony production
maximally at day 14 (data not presented). The dose-response
curves of eosinophil colony production by mEDF-CM are
shown in Fig 6B, the lowest detectable mEDF dilution
varying from 1:l0￿ to 1 :102, and Table 2 shows the 50-fold
variation in 50% end points.
DISCUSSION
Few lymphokines show cross-species activity between
mouse and human; however, where they exist, they have
provided a means for studying activities when the homolo-
gous factor has not been available. In this paper mEDF has
been used to study human eosinophil hematopoiesis (because
this source of mEDF is known to be free of other lympho-
kines4 and produces selective eosinophil colony production).5
Other factors known to induce eosinophil differentiation are
granulocyte-macrophage colony-stimulating factor (GM-
CSF)’#{176}and interleukin 3,” but their activitiy is not specific
to the eosinophil lineage, so eosinophils are produced along
with large numbers of other cell types.
It is shown that functionally active human eosinophils can
be produced, which opens up the possibility of studying
eosinophil differentiation and activation under controlled
conditions. The time required for maximal eosinophil pro-
duction in the liquid culture system (21 to 35 days) is similar
to that previously reported for maximal colony formation,’2”3
and eosinophils of more than 90% viability were maintained
in culture for up to 7 weeks.
The morphology and maturation of eosinophils produced
in liquid culture by mEDF resembled that seen in the bone
marrow of normal subjects. Eosinophil maturation in cob-
nies has been studied by Zucker-Franklin et al who used
peripheral blood lymphocytes stimulated by white cell under-
layers.’4 They found that promyelocytes were present on day
9, with myelocytes and metamyelocytes being most prevalent
on days 15 and 21. Our colony results were similar, but the
stage of maturation in the liquid culture system was delayed
by about I week. The main difference between cultured
mature eosinophils and circulating eosinophils was the
Table 2. Summary of Results of Do se Response of Individual Marrow Cultures
50% End Point
Ratio of Eosinophil Peroxidase
mEDF Experiment Count Colony Assay Assay (hEPO) mEPO/hEPOt
mEDF-PP 1
2
3
32
20￿
100
135
150
969
11.6
10.4
1.6
mEDF-CM 6
9
10
11
12
72
135
28￿
48
31*
2,156
279
395
4.4
3.1
15
17
215
39
18
19
20
21
22
52
53
99
62
43
924
￿5*
117
1,722
137
148
146
40
137
8.4
8.5
31
9.0
Abbreviations: mEPO, murine EPO; hEPO, human EPO.
Reciprocal of the dilution, calculated from results at a 1: 10 dilution of mEDF where no plateau was reached (*).
tmEPO - 50% end point in the mouse peroxidase assay (mEDF-PP - 1.565; mEDF-CM - 1.236).
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absence of crystalline cores in the granules. A similar obser-
vation was made by Zucker-Franklin et al’4 and Butterfield
et al’2 in their studies of eosinophil colonies. Like these
workers found, granules with cores of low electron density3
were not detected.
An array of different factors including mEDF have been
shown to activate eosinophils.’5 This term is usually used to
describe an increase in activity in a short-term assay, but no
clear idea of the mechanisms behind activation has emerged.
It is not clear whether it is a part of the differentiation
pathway or a separate, perhaps reversible, pathway. If
activation were a final step in differentiation, only fully
mature cells would exhibit fully functional activity.
Cultured eosinophils were as functional in an ADCC assay
as peripheral blood eosinophils.5 Moreover, it appears that
this functional activity is present to the same degree in both
immature eosinophil myelocytes and mature cells produced
in vitro. Mature cells, however, lost their activity after 7
weeks despite being more than 90% viable and having normal
light-microscopic appearances. This may indicate that func-
tional activity is of shorter duration than cell viability
assessed by trypan blue exclusion or that other factors may
be required at this stage to maintain functional activity.
The cytotoxic activity of peripheral blood eosinophils has
been reported to be dependent on the presence of activating
factors.5”0” In the present study, however, cultured eosino-
phils alone were cytotoxic, and the effect of the presence of
mEDF was small, which suggests that the eosinophils were
already partially activated. In an attempt to test whether
activation was reversible, cultured eosinophils were deprived
I . Pincus SH, Schooley WR, DiNapoli AM, Broder 5: Metabolic
heterogeneity of eosinophils from normal and hypereosinophilic
patients. Blood 58:1 175, 1981
2. Metcalf D, Cutler RL, Nicola NA: Selective stimulation by
mouse spleen cell conditioned medium of human eosinophil colony
formation. Blood 61:999, 1983
3. Shoham D, David EB, Rozenszajn LA: Cytochemical and
morphologic identification of macrophages and eosinophils in tissue
cultures of normal human bone marrow. Blood 44:22 1, 1974
4. Sanderson Ci, Warren Di, Strath M: Identification of a
lymphokine that stimulates eosinophil differentiation in vitro. Its
relationship to interleukin 3, and functional properties of eosinophils
produced in cultures. J Exp Med 162:60, 1985
5. Lopez AF, Begley CG, Williamson Di, Warren Di, Vadas
MA, Sanderson Ci: Murine eosinophil differentiation factor: An
eosinophil-specific colony-stimulating factor with activity for human
cells. J Exp Med 163:1085, 1986
6. Metcalf D: The Hemopoietic Colony Stimulating Factors.
Amsterdam, Elsevier, 1984
7. Strath M, Warren Di, Sanderson Ci: Detection of eosinophils
using an eosinophil peroxidase assay. Its use as an assay for
eosinophil differentiation factors. J Immunol Methods 83:209, 1985
8. Warren Di, Sanderson Ci: Production of a T cell hybrid
producing a lymphokine stimulating eosinophil differentiation.
Immunology 54:615, 1985
9. Vadas MA, Nicola NA, Metcalf D: Activation of antibody-
dependent cell-mediated cytotoxicity of human neutrophils and
eosinophils by separate colony-stimulating factors. J Immunol
130:795, 1983
10. MetcalfD, Begley CG, Johnson GR, Nicola NA, Vadas MA,
of mEDF. It was surprising to find that eosinophil numbers
were well maintained for up to six days in the absence of
mEDF with little loss of cytotoxic activity because previous
work has shown that 50% of peripheral blood eosinophils
survive only 36 hours in the absence of mEDF.’6 It is possible
that mEDF was not removed by washing but remained
bound to glycosaminoglycans in the extracellular matrix as
shown for GM-CSF.’7 Nonetheless, the observation that
cultured immature eosinophil myelocytes are as active as
mature cells and that both cell types appeared to be partially
activated suggest that activation is a separate pathway from
differentiation.
Human hematopoietic growth factors are mainly assayed
by their ability to induce colony formation. As in the mouse,7
a liquid culture system using either differential cell counting
or peroxidase assay was shown to be a useful alternative. It is
interesting to note that in the mouse the colony assay is very
insensitive compared with liquid cultures.5’8 None of these
assay systems, however, provides an ideal assay for eosino-
phil differentiation factors in humans because human bone
marrow is not readily available and the culture periods are
lengthy. Human bone marrow is less sensitive than murine
bone marrow at detecting murine EDF. It remains to be seen
whether human EDF is active on mouse cells because this
would provide an assay system with several advantages over
the human bone marrow systems.
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